Evidence map›Paper›PMID 41976344›Full record

ArticleCancers2026

Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas.

Sofía Huerga-Domínguez, Beñat Ariceta, Paula Aguirre-Ruiz, Patxi San Martín-Uriz, Sarai Sarvide, Álvaro López-Janeiro, Diego Alignani, Aitziber López, Teresa Ezponda, Rocío Figueroa and 10 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sofía Huerga-DomínguezHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Beñat AricetaCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Paula Aguirre-RuizCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Patxi San Martín-UrizCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.ORCID 0000-0003-1483-4279
Sarai SarvideCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Álvaro López-JaneiroDepartment of Pathological Anatomy, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-5744-3115
Diego AlignaniCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Aitziber LópezCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Teresa EzpondaCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.ORCID 0000-0003-3682-7125
Rocío FigueroaHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0002-2773-4982
Carlos GrandeHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Ana AlfonsoHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0002-2478-5354
Esther PenaHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Santiago BrowneHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.ORCID 0009-0001-9300-6756
Ramón RobledanoDepartment of Pathological Anatomy, Clínica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0009-0001-3524-9020
Amaia Vilas-ZornozaCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Sergio RoaCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Jose Ángel Martínez-ClimentCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
Felipe PrósperHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0001-6115-8790
Miguel CanalesHematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0002-6550-2621

Funding

Asociación Española Contra el Cáncer Ayudas talento en el territorio Clínico Junior AECC 2024Centro de Investigación Biomédica en Red de Cáncer CB16/12/00489Instituto de Salud Carlos III PMP21/00015 (PREGENLINF)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diffuse large B-cell lymphomafollicular lymphomahistological transformationsingle-cell DNA sequencingsingle-cell RNA sequencingspatial transcriptomicstumor microenvironment

Identifiers

PMID41976344
PMCPMC13072214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.